Authors:
Koistinen, HA
Remitz, A
Gylling, H
Miettinen, TA
Koivisto, VA
Ebeling, P
Citation: Ha. Koistinen et al., Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid, DIABET M R, 17(5), 2001, pp. 391-395
Authors:
Koistinen, HA
Vidal, H
Karonen, SL
Dusserre, E
Vallier, P
Koivisto, VA
Ebeling, P
Citation: Ha. Koistinen et al., Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men, ART THROM V, 21(6), 2001, pp. 1034-1039
Authors:
Laivuori, H
Koistinen, HA
Karonen, SL
Cacciatore, B
Ylikorkala, O
Citation: H. Laivuori et al., Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women, HUM REPR, 16(8), 2001, pp. 1632-1635
Authors:
Unkila-Kallio, L
Andersson, S
Koistinen, HA
Karonen, SL
Ylikorkala, O
Tiitinen, A
Citation: L. Unkila-kallio et al., Leptin during assisted reproductive cycles: the effect of ovarian stimulation and of very early pregnancy, HUM REPR, 16(4), 2001, pp. 657-662
Authors:
Ebeling, P
Teppo, AM
Koistinen, HA
Koivisto, VA
Citation: P. Ebeling et al., Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes, METABOLISM, 50(3), 2001, pp. 283-287
Authors:
Koistinen, HA
Dusserre, E
Ebeling, P
Vallier, P
Koivisto, VA
Vidal, H
Citation: Ha. Koistinen et al., Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects, DIABET M R, 16(5), 2000, pp. 364-369
Authors:
Oksanen, L
Tiitinen, A
Kaprio, J
Koistinen, HA
Karonen, SL
Kontula, K
Citation: L. Oksanen et al., No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome, MOL HUM REP, 6(10), 2000, pp. 873-876
Authors:
Marttunen, MB
Andersson, S
Hietanen, P
Karonen, SL
Koistinen, HA
Koivisto, VA
Tiitinen, A
Ylikorkala, O
Citation: Mb. Marttunen et al., Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients, MATURITAS, 35(2), 2000, pp. 175-179
Authors:
Binnert, C
Koistinen, HA
Martin, GV
Andreelli, F
Ebeling, P
Koivisto, VA
Laville, M
Auwerx, J
Vidal, H
Citation: C. Binnert et al., Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans, AM J P-ENDO, 279(5), 2000, pp. E1072-E1079
Authors:
Koistinen, HA
Bastard, JP
Dusserre, E
Ebeling, P
Zegari, N
Andreelli, F
Jardel, C
Donner, M
Meyer, L
Moulin, P
Hainque, B
Riou, JP
Laville, M
Koivisto, VA
Vidal, H
Citation: Ha. Koistinen et al., Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects, EUR J CL IN, 30(4), 2000, pp. 302-310
Authors:
Hytinantti, TK
Koistinen, HA
Teramo, K
Karonen, SL
Koivisto, VA
Andersson, S
Citation: Tk. Hytinantti et al., Increased fetal leptin in Type I diabetes mellitus pregnancies complicatedby chronic hypoxia, DIABETOLOG, 43(6), 2000, pp. 709-713
Authors:
Hytinantti, T
Koistinen, HA
Koivisto, VA
Karonen, SL
Andersson, S
Citation: T. Hytinantti et al., Changes in leptin concentration during the early postnatal period: Adjustment to extrauterine life?, PEDIAT RES, 45(2), 1999, pp. 197-201
Authors:
Ebeling, P
Teppo, AM
Koistinen, HA
Viikari, J
Ronnemaa, T
Nissen, M
Bergkulla, S
Salmela, P
Saltevo, J
Koivisto, VA
Citation: P. Ebeling et al., Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes, DIABETOLOG, 42(12), 1999, pp. 1433-1438